Drug intelligence / Profile preview

Lactoflorene Plus

Development stage: Unknown
Lead developer: Montefarmaco
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactoflorene Plus is a multi-strain probiotic dietary supplement developed by Montefarmaco to promote the balance of intestinal bacterial flora. It contains a specific blend of live lactic acid bacteria, including Lactobacillus acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12, Lactobacillus paracasei L.Casei431, and Bacillus coagulans BC513. The formulation is further enriched with zinc and a B-complex vitamin profile (including thiamine, riboflavin, pyridoxine, cyanocobalamin, niacin, pantothenic acid, and folic acid) to support the immune system and energy metabolism. It is indicated for conditions such as dysbiosis resulting from antibiotic therapy, diarrhea of various origins, constipation, and abdominal bloating. The product is available in multiple delivery formats, including gastro-resistant capsules, vials with separator caps, and orosoluble sachets, and is formulated to be gluten-free and lactose-free.

Brand names: Lactoflorene Plus
Other names: Lactoflorene Plus

Beyond the preview

Go deeper on Lactoflorene Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactoflorene Plus.

Explore the full profile